MedTrace Logo

The SpeedPlate™ Rapid Compression Implant Study (The SPRINT™ Study)

NCT06548581 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 92

Last updated 2025-06-11

No results posted yet for this study

Summary

Post-market, observational, multicenter, unblinded, ambidirectional cohort study to evaluate outcomes of study participants treated with the SpeedPlate™ product.

Up to 200 participants will be treated in this study at (up to) 15 clinical sites.

Patients 14 years of age or older that have had MTP and/or TMT joint fixation with the SpeedPlate™ Rapid Compression Implants will be eligible to participate based on the inclusion and exclusion criteria defined in this protocol.

Conditions

  • Joint Arthrodesis
  • Joint Fixation

Interventions

DEVICE

SpeedPlate™ Rapid Compression Implants

MTP and/or TMT joint fixation with SpeedPlate™ Rapid Compression Implants

Sponsors & Collaborators

  • Treace Medical Concepts, Inc.

    lead INDUSTRY

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-04
Primary Completion
2026-03-31
Completion
2026-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06548581 on ClinicalTrials.gov